Abstract
Summary
The global Rectopexy Mesh and Graft market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rectopexy Mesh and Graft is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rectopexy Mesh and Graft is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rectopexy Mesh and Graft is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rectopexy Mesh and Graft players cover Johnson & Johnson, C. R. Bard Inc., Medtronic plc, Cook Medical, Tepha, Atrium, Ethicon, ALTAYLAR medical and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The posterior mesh rectopexy involves insertion of a mesh behind a completely mobilized rectum and its fixation to the sacrum as well as to the sides of the rectum. Laparoscopic mesh rectopexy is performed with synthetic meshes such as polypropylene or absorbable meshes such as polyglactin and polyglycolic acid.
LPI (LP Information)' newest research report, the “Rectopexy Mesh and Graft Industry Forecast” looks at past sales and reviews total world Rectopexy Mesh and Graft sales in 2022, providing a comprehensive analysis by region and market sector of projected Rectopexy Mesh and Graft sales for 2023 through 2029. With Rectopexy Mesh and Graft sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rectopexy Mesh and Graft industry.
This Insight Report provides a comprehensive analysis of the global Rectopexy Mesh and Graft landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rectopexy Mesh and Graft portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rectopexy Mesh and Graft market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rectopexy Mesh and Graft and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rectopexy Mesh and Graft.
This report presents a comprehensive overview, market shares, and growth opportunities of Rectopexy Mesh and Graft market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Synthetic Mesh
Biological Grafts
Segmentation by application
Ambulatory Surgical Centers
Hospitals & Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
C. R. Bard Inc.
Medtronic plc
Cook Medical
Tepha
Atrium
Ethicon
ALTAYLAR medical
Bio-Rad
Molnlycke Healthcare
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rectopexy Mesh and Graft market?
What factors are driving Rectopexy Mesh and Graft market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rectopexy Mesh and Graft market opportunities vary by end market size?
How does Rectopexy Mesh and Graft break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
United States market for Rectopexy Mesh and Graft is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rectopexy Mesh and Graft is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rectopexy Mesh and Graft is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rectopexy Mesh and Graft players cover Johnson & Johnson, C. R. Bard Inc., Medtronic plc, Cook Medical, Tepha, Atrium, Ethicon, ALTAYLAR medical and Bio-Rad, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
The posterior mesh rectopexy involves insertion of a mesh behind a completely mobilized rectum and its fixation to the sacrum as well as to the sides of the rectum. Laparoscopic mesh rectopexy is performed with synthetic meshes such as polypropylene or absorbable meshes such as polyglactin and polyglycolic acid.
LPI (LP Information)' newest research report, the “Rectopexy Mesh and Graft Industry Forecast” looks at past sales and reviews total world Rectopexy Mesh and Graft sales in 2022, providing a comprehensive analysis by region and market sector of projected Rectopexy Mesh and Graft sales for 2023 through 2029. With Rectopexy Mesh and Graft sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rectopexy Mesh and Graft industry.
This Insight Report provides a comprehensive analysis of the global Rectopexy Mesh and Graft landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rectopexy Mesh and Graft portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Rectopexy Mesh and Graft market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rectopexy Mesh and Graft and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rectopexy Mesh and Graft.
This report presents a comprehensive overview, market shares, and growth opportunities of Rectopexy Mesh and Graft market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Synthetic Mesh
Biological Grafts
Segmentation by application
Ambulatory Surgical Centers
Hospitals & Specialty Clinics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
C. R. Bard Inc.
Medtronic plc
Cook Medical
Tepha
Atrium
Ethicon
ALTAYLAR medical
Bio-Rad
Molnlycke Healthcare
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rectopexy Mesh and Graft market?
What factors are driving Rectopexy Mesh and Graft market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rectopexy Mesh and Graft market opportunities vary by end market size?
How does Rectopexy Mesh and Graft break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rectopexy Mesh and Graft Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rectopexy Mesh and Graft by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rectopexy Mesh and Graft by Country/Region, 2018, 2022 & 2029
2.2 Rectopexy Mesh and Graft Segment by Type
2.2.1 Synthetic Mesh
2.2.2 Biological Grafts
2.3 Rectopexy Mesh and Graft Sales by Type
2.3.1 Global Rectopexy Mesh and Graft Sales Market Share by Type (2018-2023)
2.3.2 Global Rectopexy Mesh and Graft Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rectopexy Mesh and Graft Sale Price by Type (2018-2023)
2.4 Rectopexy Mesh and Graft Segment by Application
2.4.1 Ambulatory Surgical Centers
2.4.2 Hospitals & Specialty Clinics
2.5 Rectopexy Mesh and Graft Sales by Application
2.5.1 Global Rectopexy Mesh and Graft Sale Market Share by Application (2018-2023)
2.5.2 Global Rectopexy Mesh and Graft Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rectopexy Mesh and Graft Sale Price by Application (2018-2023)
3 Global Rectopexy Mesh and Graft by Company
3.1 Global Rectopexy Mesh and Graft Breakdown Data by Company
3.1.1 Global Rectopexy Mesh and Graft Annual Sales by Company (2018-2023)
3.1.2 Global Rectopexy Mesh and Graft Sales Market Share by Company (2018-2023)
3.2 Global Rectopexy Mesh and Graft Annual Revenue by Company (2018-2023)
3.2.1 Global Rectopexy Mesh and Graft Revenue by Company (2018-2023)
3.2.2 Global Rectopexy Mesh and Graft Revenue Market Share by Company (2018-2023)
3.3 Global Rectopexy Mesh and Graft Sale Price by Company
3.4 Key Manufacturers Rectopexy Mesh and Graft Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rectopexy Mesh and Graft Product Location Distribution
3.4.2 Players Rectopexy Mesh and Graft Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rectopexy Mesh and Graft by Geographic Region
4.1 World Historic Rectopexy Mesh and Graft Market Size by Geographic Region (2018-2023)
4.1.1 Global Rectopexy Mesh and Graft Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rectopexy Mesh and Graft Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rectopexy Mesh and Graft Market Size by Country/Region (2018-2023)
4.2.1 Global Rectopexy Mesh and Graft Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rectopexy Mesh and Graft Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rectopexy Mesh and Graft Sales Growth
4.4 APAC Rectopexy Mesh and Graft Sales Growth
4.5 Europe Rectopexy Mesh and Graft Sales Growth
4.6 Middle East & Africa Rectopexy Mesh and Graft Sales Growth
5 Americas
5.1 Americas Rectopexy Mesh and Graft Sales by Country
5.1.1 Americas Rectopexy Mesh and Graft Sales by Country (2018-2023)
5.1.2 Americas Rectopexy Mesh and Graft Revenue by Country (2018-2023)
5.2 Americas Rectopexy Mesh and Graft Sales by Type
5.3 Americas Rectopexy Mesh and Graft Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rectopexy Mesh and Graft Sales by Region
6.1.1 APAC Rectopexy Mesh and Graft Sales by Region (2018-2023)
6.1.2 APAC Rectopexy Mesh and Graft Revenue by Region (2018-2023)
6.2 APAC Rectopexy Mesh and Graft Sales by Type
6.3 APAC Rectopexy Mesh and Graft Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rectopexy Mesh and Graft by Country
7.1.1 Europe Rectopexy Mesh and Graft Sales by Country (2018-2023)
7.1.2 Europe Rectopexy Mesh and Graft Revenue by Country (2018-2023)
7.2 Europe Rectopexy Mesh and Graft Sales by Type
7.3 Europe Rectopexy Mesh and Graft Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rectopexy Mesh and Graft by Country
8.1.1 Middle East & Africa Rectopexy Mesh and Graft Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rectopexy Mesh and Graft Revenue by Country (2018-2023)
8.2 Middle East & Africa Rectopexy Mesh and Graft Sales by Type
8.3 Middle East & Africa Rectopexy Mesh and Graft Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rectopexy Mesh and Graft
10.3 Manufacturing Process Analysis of Rectopexy Mesh and Graft
10.4 Industry Chain Structure of Rectopexy Mesh and Graft
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rectopexy Mesh and Graft Distributors
11.3 Rectopexy Mesh and Graft Customer
12 World Forecast Review for Rectopexy Mesh and Graft by Geographic Region
12.1 Global Rectopexy Mesh and Graft Market Size Forecast by Region
12.1.1 Global Rectopexy Mesh and Graft Forecast by Region (2024-2029)
12.1.2 Global Rectopexy Mesh and Graft Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rectopexy Mesh and Graft Forecast by Type
12.7 Global Rectopexy Mesh and Graft Forecast by Application
13 Key Players Analysis
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Information
13.1.2 Johnson & Johnson Rectopexy Mesh and Graft Product Portfolios and Specifications
13.1.3 Johnson & Johnson Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Johnson & Johnson Main Business Overview
13.1.5 Johnson & Johnson Latest Developments
13.2 C. R. Bard Inc.
13.2.1 C. R. Bard Inc. Company Information
13.2.2 C. R. Bard Inc. Rectopexy Mesh and Graft Product Portfolios and Specifications
13.2.3 C. R. Bard Inc. Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 C. R. Bard Inc. Main Business Overview
13.2.5 C. R. Bard Inc. Latest Developments
13.3 Medtronic plc
13.3.1 Medtronic plc Company Information
13.3.2 Medtronic plc Rectopexy Mesh and Graft Product Portfolios and Specifications
13.3.3 Medtronic plc Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Medtronic plc Main Business Overview
13.3.5 Medtronic plc Latest Developments
13.4 Cook Medical
13.4.1 Cook Medical Company Information
13.4.2 Cook Medical Rectopexy Mesh and Graft Product Portfolios and Specifications
13.4.3 Cook Medical Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Cook Medical Main Business Overview
13.4.5 Cook Medical Latest Developments
13.5 Tepha
13.5.1 Tepha Company Information
13.5.2 Tepha Rectopexy Mesh and Graft Product Portfolios and Specifications
13.5.3 Tepha Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Tepha Main Business Overview
13.5.5 Tepha Latest Developments
13.6 Atrium
13.6.1 Atrium Company Information
13.6.2 Atrium Rectopexy Mesh and Graft Product Portfolios and Specifications
13.6.3 Atrium Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Atrium Main Business Overview
13.6.5 Atrium Latest Developments
13.7 Ethicon
13.7.1 Ethicon Company Information
13.7.2 Ethicon Rectopexy Mesh and Graft Product Portfolios and Specifications
13.7.3 Ethicon Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Ethicon Main Business Overview
13.7.5 Ethicon Latest Developments
13.8 ALTAYLAR medical
13.8.1 ALTAYLAR medical Company Information
13.8.2 ALTAYLAR medical Rectopexy Mesh and Graft Product Portfolios and Specifications
13.8.3 ALTAYLAR medical Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 ALTAYLAR medical Main Business Overview
13.8.5 ALTAYLAR medical Latest Developments
13.9 Bio-Rad
13.9.1 Bio-Rad Company Information
13.9.2 Bio-Rad Rectopexy Mesh and Graft Product Portfolios and Specifications
13.9.3 Bio-Rad Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Bio-Rad Main Business Overview
13.9.5 Bio-Rad Latest Developments
13.10 Molnlycke Healthcare
13.10.1 Molnlycke Healthcare Company Information
13.10.2 Molnlycke Healthcare Rectopexy Mesh and Graft Product Portfolios and Specifications
13.10.3 Molnlycke Healthcare Rectopexy Mesh and Graft Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Molnlycke Healthcare Main Business Overview
13.10.5 Molnlycke Healthcare Latest Developments
14 Research Findings and Conclusion